U.S. investment firm Gurnet Point Capital is nearing a deal to acquire Ireland-based specialty drugmaker Innocoll Holdings Plc (INNL.O), people familiar with the matter said on Tuesday. The deal would add the...
Capital International buys 3% stake in Intas Pharmaceuticals for $107 million
Capital International Private Equity Fund has acquired about 3% of Intas Pharmaceuticals Ltd for $107 million (Rs690 crore) from ChrysCapital Llc., according to two people aware of the development. The transaction...
Mankind Pharma mulls to invest Rs 305-crore in Pathkind Diagnostics
Mankind Pharma today said it has plans to invest Rs 305 crore in its new venture Pathkind Diagnostics in the next 4 years. Mankind Pharma is a USD 800 million pharmaceutical firm. “We are foraying into diagnostics...
PPD’s private equity owners in talks to sell stakes – sources
The two buyout firms that own Pharmaceutical Product Development LLC (PPD) are in advanced talks to sell some of their stakes in the U.S. clinical trials firm at a price that would value the entire company at more than...
Jubilant Life Sciences looks to buy specialty pharma business in US
Jubilant Life Sciences today said its subsidiary Jubilant Pharma will negotiate a potential acquisition of a specialty business in the US. “The Board of Directors of Jubilant Pharma Ltd, a material wholly-owned...
Piramal acquires Mallinckrodt LLC’s pain drug portfolio
Piramal Enterprises today said it has completed acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt LLC. Piramal in January had announced the acquisition for a cash consideration of...
Ackman’s Pershing Square sells Valeant stake, takes $3 billion loss
Billionaire investor William Ackman walked away from Valeant Pharmaceuticals International Inc on Monday with a loss of more than $3 billion as he sold his entire stake in the struggling drug company after trying to...
China’s Fosun Pharma set to join bidding for Germany’s Stada: sources
China’s Shanghai Fosun Pharmaceutical (600196.SS) is planning a bid for German generic drugmaker Stada (STAGn.DE), already the center of a 3.6 billion-euro ($3.8 billion) takeover battle between two private equity...
Novo Nordisk in bid for Global Blood Therapeutics – sources
Danish drugmaker Novo Nordisk A/S (NOVOb.CO) has approached Global Blood Therapeutics Inc (GBT.O), a U.S. biotechnology company focused on serious blood disorders, to discuss a potential acquisition, people familiar...
CCI approves Corona Remedies-GlaxoSmithKline deal
The Competition Commission has cleared the proposed acquisition of four drug brands of GlaxoSmithKline by Corona Remedies. Dilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona...
Ranbaxy’s Singh brothers must seek permission to sell assets: High Court
The Delhi High Court told former RanbaxyBSE 5.63 % promoters Malvinder and Shivinder Singh that they will have to seek its permission before selling any of their unencumbered assets. That could complicate reported plans...
Cipla divests animal health business in South Africa, sub-Saharan Africa
India’s third-largest drugmaker CiplaBSE 0.69 % said it sold its animal health business to South Africa’s Ascendis Health, as part of the company’s strategy to focus on consolidating its business to strategic markets...
